Christopher B. Ehrlich

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher B. Ehrlich:

Company Role Class Num Shares Value Price $ Report Date Ownership
CERO THERAPEUTICS HOLDINGS, INC. Chairman and CEO, Director Stock Option (Right to Buy) 4,530,997 07 Jan 2026 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 13 Jun 2024 Direct

Insider Reports Filed by Christopher B. Ehrlich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CERO CERO THERAPEUTICS HOLDINGS, INC. 07 Jan 2026 1 $0 4 Chairman and CEO, Director 09 Jan 2026, 16:30
CERO CERO THERAPEUTICS HOLDINGS, INC. 30 May 2025 1 $0 4 Chairman and CEO, Director 02 Jun 2025, 17:04
CERO CERO THERAPEUTICS HOLDINGS, INC. 04 Mar 2025 1 $0 4 Chairman and CEO, Director 06 Mar 2025, 16:10
CERO CERO THERAPEUTICS HOLDINGS, INC. 24 Feb 2025 1 $0 4 Chairman and CEO, Director 26 Feb 2025, 17:59
CERO CERO THERAPEUTICS HOLDINGS, INC. 02 Dec 2024 1 $0 4 Chairman and CEO, Director 04 Dec 2024, 21:13
CERO CERO THERAPEUTICS HOLDINGS, INC. 25 Sep 2024 3 -$275,000 4 Interim Chairman and CEO, Director 02 Oct 2024, 21:53
LPAA Launch One Acquisition Corp. 11 Jul 2024 0 $0 3 Chief Executive Officer, Director 11 Jul 2024, 18:07
/report/000095017024073204-ehrlich-christopher-b-2024-06-13 eFFECTOR Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 13 Jun 2024, 18:25
CERO CERO THERAPEUTICS HOLDINGS, INC. 25 Mar 2024 1 $0 4 Director 27 Mar 2024, 21:27
/report/000120919124003702-ehrlich-christopher-b-2024-02-19 eFFECTOR Therapeutics, Inc. 19 Feb 2024 1 $0 4 Director 21 Feb 2024, 17:25
CERO PHOENIX BIOTECH ACQUISITION CORP. 14 Feb 2024 11 +$275,000 4 Director 16 Feb 2024, 19:37
/report/000120919123039193-ehrlich-christopher-b-2023-06-22 eFFECTOR Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 22 Jun 2023, 20:09
/report/000120919123004581-ehrlich-christopher-b-2023-01-20 eFFECTOR Therapeutics, Inc. 20 Jan 2023 1 $0 4 Director 24 Jan 2023, 15:07
/report/000120919122052933-ehrlich-christopher-b-2022-10-04 eFFECTOR Therapeutics, Inc. 04 Oct 2022 1 +$197 4 Director 06 Oct 2022, 08:30
/report/000120919122051313-ehrlich-christopher-b-2022-09-26 eFFECTOR Therapeutics, Inc. 26 Sep 2022 1 +$10,377 4 Director 27 Sep 2022, 08:01
/report/000120919122036443-ehrlich-christopher-b-2022-06-09 eFFECTOR Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:39
/report/000120919122011731-ehrlich-christopher-b-2022-02-14 eFFECTOR Therapeutics, Inc. 14 Feb 2022 2 +$13,200 4 Director 22 Feb 2022, 15:59
/report/000120919122008529-ehrlich-christopher-b-2022-02-08 eFFECTOR Therapeutics, Inc. 08 Feb 2022 2 +$9,670 4 Director 10 Feb 2022, 16:05
/report/000120919122007349-ehrlich-christopher-b-2022-02-03 eFFECTOR Therapeutics, Inc. 03 Feb 2022 2 +$30,750 4 Director 07 Feb 2022, 08:00
/report/000120919122005721-ehrlich-christopher-b-2022-01-27 eFFECTOR Therapeutics, Inc. 27 Jan 2022 1 +$26,515 4 Director 31 Jan 2022, 16:50
CERO PHOENIX BIOTECH ACQUISITION CORP. 08 Oct 2021 3 +$367,330 4 CEO and Secretary, Director, 10%+ Owner 12 Oct 2021, 19:36
/report/000120919121060079-ehrlich-christopher-b-2021-10-06 eFFECTOR Therapeutics, Inc. 06 Oct 2021 1 $0 4 Director 08 Oct 2021, 17:22
CERO PHOENIX BIOTECH ACQUISITION CORP. 05 Oct 2021 0 $0 3 CEO and and Secretary, Director, 10%+ Owner 05 Oct 2021, 18:54
/report/000120919121053731-ehrlich-christopher-b-2021-08-25 eFFECTOR Therapeutics, Inc. 25 Aug 2021 6 $0 4 Director 27 Aug 2021, 18:53